Arch. Pharm. Chem. Life Sci. 2008, 341, 701–707
Pyrazoline Derivatives as Antidepressant – Anticonvulsant
705
11.27 Hz, 1H, HX), 6.90 (b, 1H, NH), 6.90–7.50 (m, 6H, thiophene);
MS m/e: 293 [M+] (89%), 260 [M – SH] (70%), 233 [M – CSNH2]
(34%), 183 [M – C5H4NS] (75%), 169 [M – C5H4N2S] (100%), 151
[C7H7N2S] (24%), 110 [C5H4NS] (57%). Anal. Calcd. for C12H11N3S3: C,
49.12; H, 3.78; N, 14.32; S, 32.78. Found: C, 49.53; H, 4.20; N,
14.38; S, 32.34.
CSNHC3H5] (77%), 151 [C7H7N2S] (66%), 110 [C5H4NS] (46%), 104
[C7H6N] (86%). Anal. Calcd. for C17H17N3OS2: C, 62.35; H, 5.23; N,
12.83; S, 19.58. Found: C, 62.72; H, 5.18; N, 12.86; S, 19.91.
1-N-Phenylthiocarbamoyl-3-(2-thienyl)-5-phenyl-2-
pyrazoline 8
MeOH
Maks
Yield: 67%; m.p.: 122–38C (Crys. solv.: EtOH); UV k
[nm]: 202
1-N-substituted-thiocarbamoyl-3-(2-thienyl)-5-phenyl/(2-
thienyl)-2-pyrazolines 5–12
(log e: 4.47), 251 (log e: 4.43), 346 (log e: 4.22); IR m (KBr) [cm– 1]
3343 (N-H stretching), 1588, 1513 (C=N stretching), 1451 (C4-H-
deformation), 1343 (C=S stretching), 1169 (C5-N1 stretching); H-
1
Hydrazine hydrate (0.02 mol) was added to an ethanolic solution
of appropriate chalcone (0.01 mol, 10 mL ethanol) and refluxed
for 2 h. The solvent was evaporated at reduced pressure. The resi-
due was dissolved in dry ether. Isothiocyanate (0.01 mol) and
four drops of triethylamine were added and stirred at room tem-
perature for 4 h. The mixture was evaporated to dryness and the
residue was crystallized from the proper solvent.
NMR d (CDCl3) [ppm]: 3.20 (dd, JAB = 17.60 Hz, JAX = 3.40 Hz, 1H,
HA), 3.90 (dd, JAB = 17.62 Hz, JBX = 11.50 Hz, 1H, HB), 6.20 (dd, JAX
=
3.37 Hz, JBX = 11.50 Hz, 1H, HX), 7.10–7.70 (m, 13H, thiophene
and benzene), 9.15 (s, 1H, NH); MS m/e: 363 [M+] (73%), 330 [M –
SH] (75%), 271 [M – C6H5NH] (77%), 253 [M – C5H4NS] (43%), 227
[M – CSNHC6H5] (79%), 162 [C8H6N2S] (100%), 151 [C7H7N2S] (64%),
110 [C5H4NS] (30%). Anal. Calcd. for C20H17N3S2: C, 66.08; H, 4.71;
N, 11.56; S, 17.64. Found: C, 66.47; H, 5.07; N, 11.57; S, 17.50.
1-N-Methylthiocarbamoyl-3-(2-thienyl)-5-phenyl-2-
pyrazoline 5
Yield: 60%; m.p.: 138–1398C (Crys. solv.: EtOH / H2O); UV kMMaeOksH
[nm]: 203 (log e: 4.22), 246 (log e: 4.17), 341 (log e: 3.89); IR m (KBr)
[cm– 1]: 3371 (N-H stretching), 1590, 1435 (C=N stretching), 1388
(C4-H-deformation), 1343 (C=S stretching), 1110 (C5-N1 stretch-
1-N-Methylthiocarbamoyl-3,5-di-(2-thienyl)-2-pyrazoline
9
Yield: 53%; m.p.: 149–1508C (Crys. solv.: EtOH / H2O); UV kMMaeOksH
[nm]: 223 (log e: 4.20 ), 243 (log e: 4.03), 340 (log e: 4.01); IR m (KBr)
[cm– 1]: 3321 (N-H stretching), 1531 (C=N stretching), 1431, 1387
(C4-H-deformation), 1351 (C=S stretching), 1100 (C5-N1 stretch-
ing); 1H-NMR d (CDCl3 ) [ppm]: 3.20 (d, J = 4.65 Hz, 3H, CH3), 3.40
(dd, JAB = 17.32 Hz, JAX = 3.50 Hz, 1H, HA), 3.75 (dd, JAB = 17.40 Hz,
ing); 1H-NMR d (CDCl3) [ppm]: 3.15 (dd, JAB = 17.55 Hz, JAX
3.70 Hz, 1H, HA), 3.25 (d, J = 4.91 Hz, 3H, CH3), 3.82 (dd, JAB
17.52 Hz, JBX = 11.65 Hz, 1H, HB), 6.10 (dd, JAX = 3.63 Hz, JBX
11.68 Hz, 1H, HX), 7.00–7.55 (m, 8H, thiophene and benzene),
7.40 (b, 1H, NH); MS m/e: 301 [M+] (100%), 268 [M – SH] (75%), 227
[M – CSNHCH3] (96%), 191 [M – C5H4NS] (91%), 151 [C7H7N2S]
(87%), 110 [C5H4NS] (37%). Anal. Calcd. for C15H15N3S2: C, 59.77; H,
5.02; N, 13.94; S, 21.28. Found: C, 60.16; H, 5.07; N, 14.00; S,
20.99.
=
=
=
J
BX = 11.48 Hz, 1H, HB), 6.40 (dd, JAX = 3.41 Hz, JBX = 11.32 Hz, 1H,
HX), 6.80–7.50 (m, 6H, thiophene), 7.30 (b, 1H, NH); MS m/e: 307
[M+] (100%), 274 [M – SH] (80%), 233 [M – CSNHCH3] (70%), 218 [M
– C2H5N2S] (37%), 197 [M – C5H4NS] (74%), 183 [M – C5H4N2S]
(81%), 110 [C5H4NS] (51%). Anal. Calcd. for C13H13N3S3: C, 50.78; H,
4.26; N, 13.67; S, 31.29. Found: C, 51.04; H, 4.29; N, 13.60; S,
31.67.
1-N-Ethylthiocarbamoyl-3-(2-thienyl)-5-phenyl-2-
pyrazoline 6
Yield: 60%; m.p.: 112–1138C (Crys. solv.: EtOH / H2O); UV kMMaeOksH
[nm]: 202 (log e: 4.24), 247 (log e: 4.17), 342 (log e: 3.89); IR m (KBr)
[cm– 1]: 3348 (N-H stretching), 1511 (C=N stretching), 1443, 1369
(C4-H-deformation), 1300 (C=S stretching), 1184 (C5-N1 stretch-
ing); 1H-NMR d (CDCl3) [ppm]: 1.35 (t, J = 5.40 Hz, 3H, CH3), 3.15
(dd, JAB = 17.52 Hz, JAX = 3.64 Hz, 1H, HA), 3.60–3.90 (m, 3H, HB and
CH2), 6.10 (dd, JAX = 3.65 Hz, JBX = 11.68 Hz, 1H, HX), 7.05–7.55 (m,
8H, thiophene and benzene), 7.35 (b, 1H, NH); MS m/e: 315 [M+]
(100%), 282 [M – SH] (61%), 227 [M – CSNHC2H5] (95%), 205 [M –
C5H4NS] (47%), 151 [C7H7N2S] (73%), 110 [C5H4NS] (28%). Anal.
Calcd. for C16H17N3S2: C, 60.92; H, 5.43; N, 13.32; S, 20.33. Found:
C, 60.81; H, 6.37; N, 13.23; S, 19.89.
1-N-Ethylthiocarbamoyl-3,5-di-(2-thienyl)-2-pyrazoline 10
Yield: 57%; m.p.: 138–98C (Crys. solv.: MeOH); UV kMaks
MeOH [nm]: 200
(log e: 4.19 ), 244 (log e: 4.03), 341 (log e: 4.01); IR m (KBr) [cm– 1]:
3336 (N-H stretching), 1584, 1511 (C=N stretching), 1440, 1382
(C4-H-deformation), 1105 (C5-N1 stretching); 1H-NMR d (CDCl3)
[ppm]: 1.25 (t, JAB = 6.92, 3H, CH3), 3.30 (dd, JAB = 17.32 Hz, JAX
=
3.41 Hz, 1H, HA), 3.60–3.80 (m, 2H, CH2), 6.40 (dd, JAX = 3.31 Hz,
JBX = 11.20 Hz, 1H, HX), 6.90–7.45 (m, 6H, thiophene), 7.30 (b, 1H,
NH); MS m/e: 321 [M+] (100%), 288 [M – SH] (51%), 278 [M –
C2H5N] (71%), 233 [M – CSNHC2H5] (79%), 218 [M – C3H7N2S]
(44%), 211 [M – C5H4NS] (39%), 110 [C5H4NS] (66%). Anal. Calcd.
for C14H15N3S3: C, 52.30; H, 4.70; N, 13.07; S, 29.92. Found: C,
52.19; H, 4.10; N, 13.17; S, 30.29.
1-N-Allylthiocarbamoyl-3-(2-thienyl)-5-phenyl-2-
pyrazoline 7
1-N-Allylthiocarbamoyl-3,5-di-(2-thienyl)-2-pyrazoline 11
MeOH
Yield: 38%; m.p.: 101-1028C (Crys. solv.: EtOH / H2O); UV kMMaeOksH
[nm]: 204 (log e: 4.78), 248 (log e: 4.72), 342 (log e: 4.43); IR m (KBr)
[cm– 1]: 3370 (N-H stretching), 1508 (C=N stretching), 1441, 1368
(C4-H-deformation), 1311 (C=S stretching), 1160 (C5-N1 stretch-
Yield: 56%; m.p.: 117–1188C (Crys. solv.: MeOH); UV k
[nm]:
Maks
224 (log e: 4.30), 244 (log e: 4.32 ), 341 (log e: 4.02); IR m (KBr)
[cm–1]: 3380 (N-H stretching), 1587, 1506 (C=N stretching), 1441,
1370 (C4-H-deformation), 1158 (C5-N1 stretching); 1H-NMR d
(CDCl3) [ppm]: 3.30 (dd, JAB = 17.31 Hz, JAX = 3.40 Hz, 1H, HA), 3.75
(dd, JAB = 17.40 Hz, JBX = 11.31 Hz, 1H, HB), 4.12–4.40 (m, 2H, -CH2),
ing); 1H-NMR d (CDCl3) [ppm]: 3.20 (dd, JAB = 17.69 Hz, JAX
=
3.68 Hz, 1H, HA), 3.85 (dd, JAB = 17.51 Hz, JBX = 11.67 Hz, 1H, HB),
4.20–4.45 (m, 2H, CH2), 5.15–5.33 (m, 2H, =CH2), 5.90–6.00 (m,
1H, =CH), 6.10 (dd, JAX = 3.56 Hz, JBX = 11.60 Hz, 1H, HX), 7.05–7.50
(m, 8H, thiophene and benzene), 7.42 (b, 1H, NH); MS m/e: 327
[M+] (91%), 294 [M – SH] (18%), 271 [M – NHC3H5] (100%), 227 [M –
5.15–5.20 (m, 2H, =CH2 ), 5.90–6.10 (m, 1H, -CH=), 6.40 (dd, JAX
=
3.40 Hz, JBX = 11.32 Hz, 1H, HX), 6.90–7.50 (m, 6H, thiophene),
7.35 (b, 1H, NH); MS m/e: 333 [M+] (41%), 300 [M – SH] (18%), 277
[M – NHC3H5] (100%), 233 [M – CSNHC3H7] (50%), 218 [M –
i 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim